Min Pa: Min Pa(max): Activity's type:

Ext	Pa	Pi	Pmax	Activity	Other Results	ID Pa_max
	0.91	0.003	0.91	Anticonvulsant	0.896 0.004 DBMET00882 0.896 0.004 DBMET00933
	0.628	0.005	0.683	GABA C receptor rho-3 antagonist	0.498 0.026 DBMET00882 0.683 0.004 DBMET00933	DBMET00933
	0.618	0.004	0.618	Sigma receptor agonist	0.586 0.005 DBMET00882 0.436 0.017 DBMET00933
	0.584	0.002	0.736	Benzodiazepine agonist	0.374 0.003 DBMET00882 0.736 0.002 DBMET00933	DBMET00933
	0.58	0.007	0.658	Psychostimulant	0.658 0.005 DBMET00882 0.451 0.016 DBMET00933	DBMET00882
	0.575	0.003	0.665	GABA receptor agonist	0.482 0.004 DBMET00882 0.665 0.003 DBMET00933	DBMET00933
	0.444	0.012	0.588	Anesthetic general	0.588 0.005 DBMET00882 0.333 0.027 DBMET00933	DBMET00882
	0.367	0.025	0.367	Interleukin agonist	0.338 0.033 DBMET00882 0.363 0.026 DBMET00933
	0.344	0.004	0.796	GABA A receptor antagonist	0.193 0.006 DBMET00882 0.796 0.002 DBMET00933	DBMET00933
	0.343	0.004	0.803	GABA receptor antagonist	0.202 0.006 DBMET00882 0.803 0.002 DBMET00933	DBMET00933
	0.311	0.002	0.311	Benzodiazepine antagonist	0.142 0.003 DBMET00882 0.201 0.003 DBMET00933
	0.358	0.05	0.535	Spasmolytic	0.535 0.019 DBMET00882	DBMET00882
	0.263	0.009	0.318	GABA C receptor rho-2 antagonist	0.197 0.03 DBMET00882 0.318 0.005 DBMET00933	DBMET00933
	0.29	0.04	0.295	Gastrin inhibitor	0.25 0.079 DBMET00882 0.295 0.036 DBMET00933	DBMET00933
	0.287	0.047	0.351	Cyclic AMP phosphodiesterase inhibitor	0.351 0.025 DBMET00882 0.276 0.052 DBMET00933	DBMET00882
	0.245	0.018	0.245	Calcium channel blocker	0.215 0.024 DBMET00882
	0.236	0.022	0.236	Sodium channel blocker	0.157 0.053 DBMET00882 0.228 0.024 DBMET00933
	0.232	0.019	0.232	DNA intercalator	0.224 0.02 DBMET00882
	0.228	0.02	0.242	Sodium channel (voltage-gated) blocker	0.15 0.054 DBMET00882 0.242 0.017 DBMET00933	DBMET00933
	0.214	0.009	0.214	GABA A receptor agonist	0.144 0.017 DBMET00882 0.21 0.009 DBMET00933
	0.27	0.07	0.312	Cardiotonic	0.312 0.051 DBMET00882	DBMET00882
	0.197	0.018	0.197	Calcium channel (voltage-sensitive) blocker	0.149 0.034 DBMET00882
	0.309	0.135	0.335	Analgesic	0.262 0.172 DBMET00882 0.335 0.117 DBMET00933	DBMET00933
	0.232	0.058	0.364	Ca2+/calmodulin-dependent kinase II beta inhibitor	0.215 0.066 DBMET00882 0.364 0.02 DBMET00933	DBMET00933
	0.198	0.026	0.425	Glutamate receptor antagonist	0.168 0.04 DBMET00882 0.425 0.005 DBMET00933	DBMET00933
	0.202	0.035	0.239	ATPase inhibitor	0.209 0.03 DBMET00882 0.239 0.017 DBMET00933	DBMET00933
	0.184	0.019	0.192	Falcipain inhibitor	0.132 0.039 DBMET00882 0.192 0.017 DBMET00933	DBMET00933
	0.182	0.018	0.191	Falcipain 2 inhibitor	0.13 0.038 DBMET00882 0.191 0.015 DBMET00933	DBMET00933
	0.21	0.075	0.21	Platelet aggregation inhibitor	0.195 0.085 DBMET00882 0.21 0.074 DBMET00933
	0.211	0.078	0.261	ErbB-1 antagonist	0.206 0.083 DBMET00882 0.261 0.046 DBMET00933	DBMET00933
	0.159	0.045	0.171	Topoisomerase II inhibitor	0.171 0.041 DBMET00882	DBMET00882
	0.113	0.006	0.113	Potassium channel intermediate-conductance Ca-activated blocker	0.059 0.043 DBMET00882 0.082 0.016 DBMET00933
	0.147	0.042	0.156	Topoisomerase I inhibitor	0.156 0.039 DBMET00882	DBMET00882
	0.12	0.019	0.266	Glutamate (mGluR group I) antagonist	0.073 0.045 DBMET00882 0.266 0.005 DBMET00933	DBMET00933
	0.196	0.096	0.196	Potassium channel blocker	0.143 0.142 DBMET00882
	0.121	0.025	0.278	Glutamate (mGluR) antagonist	0.078 0.051 DBMET00882 0.278 0.005 DBMET00933	DBMET00933
	0.127	0.034	0.18	GABA C receptor rho-1 antagonist	0.089 0.08 DBMET00882 0.18 0.012 DBMET00933	DBMET00933
	0.125	0.033	0.125	Electrolyte absorption antagonist	0.111 0.044 DBMET00882 0.095 0.065 DBMET00933
	0.132	0.042	0.283	GABA C receptor antagonist	0.094 0.087 DBMET00882 0.283 0.005 DBMET00933	DBMET00933
	0.191	0.102	0.191	Potassium channel (Voltage-sensitive) blocker
	0.099	0.011	0.172	Phosphodiesterase II inhibitor	0.079 0.018 DBMET00882 0.172 0.005 DBMET00933	DBMET00933
	0.1	0.016	0.1	5 Hydroxytryptamine 5A antagonist	0.097 0.016 DBMET00933
	0.094	0.011	0.178	Glutamate (mGluR5) antagonist	0.045 0.035 DBMET00882 0.178 0.005 DBMET00933	DBMET00933
	0.131	0.049	0.171	Interleukin 8 antagonist	0.154 0.031 DBMET00882 0.171 0.023 DBMET00933	DBMET00933
	0.09	0.011	0.161	Phosphodiesterase 2A inhibitor	0.071 0.017 DBMET00882 0.161 0.005 DBMET00933	DBMET00933
	0.142	0.064	0.156	Nav1.6 sodium channel blocker	0.138 0.069 DBMET00882 0.156 0.047 DBMET00933	DBMET00933
	0.296	0.218	0.442	Ca2+/calmodulin-dependent protein kinase kinase A inhibitor	0.442 0.067 DBMET00933	DBMET00933
	0.092	0.017	0.094	5 Hydroxytryptamine 5 antagonist	0.094 0.016 DBMET00933	DBMET00933
	0.128	0.054	0.128	Calcium channel N-type blocker	0.12 0.063 DBMET00933
	0.178	0.104	0.178	HERG channel blocker
	0.093	0.02	0.1	Phospholipase D inhibitor	0.1 0.015 DBMET00882 0.094 0.019 DBMET00933	DBMET00882
	0.083	0.011	0.099	Cholecystokinin antagonist	0.055 0.022 DBMET00882 0.099 0.008 DBMET00933	DBMET00933
	0.076	0.004	0.076	Benzodiazepine receptor peripheral-type antagonist	0.058 0.005 DBMET00882 0.071 0.004 DBMET00933
	0.128	0.058	0.129	Platelet activating factor antagonist	0.129 0.057 DBMET00933	DBMET00933
	0.117	0.049	0.117	Interleukin 2 antagonist
	0.17	0.104	0.295	MAP kinase kinase 2 inhibitor	0.197 0.084 DBMET00882 0.295 0.037 DBMET00933	DBMET00933
	0.077	0.013	0.108	Cholecystokinin A antagonist	0.041 0.024 DBMET00882 0.108 0.007 DBMET00933	DBMET00933
	0.128	0.066	0.155	Nav1.3 sodium channel blocker	0.155 0.044 DBMET00882 0.127 0.066 DBMET00933	DBMET00882
	0.204	0.144	0.288	5 Hydroxytryptamine uptake stimulant	0.288 0.052 DBMET00933	DBMET00933
	0.064	0.006	0.064	Delayed rectifier potassium channel blocker	0.046 0.014 DBMET00882
	0.1	0.046	0.1	5 Hydroxytryptamine 2C antagonist	0.086 0.056 DBMET00933
	0.088	0.035	0.088	Cannabinoid receptor antagonist	0.073 0.046 DBMET00933
	0.204	0.152	0.236	Nootropic	0.236 0.121 DBMET00933	DBMET00933
	0.117	0.067	0.117	5 Hydroxytryptamine antagonist
	0.106	0.06	0.123	Nav1.1 sodium channel blocker	0.123 0.046 DBMET00882	DBMET00882
	0.15	0.105	0.198	Lipocortins synthesis antagonist	0.198 0.058 DBMET00882	DBMET00882
	0.068	0.024	0.068	Cannabinoid CB2 receptor antagonist	0.043 0.042 DBMET00882
	0.108	0.069	0.171	MAP kinase 13 inhibitor	0.171 0.028 DBMET00933	DBMET00933
	0.093	0.056	0.221	Potassium channel activator	0.221 0.007 DBMET00933	DBMET00933
	0.072	0.034	0.113	MDM2 inhibitor	0.068 0.043 DBMET00882 0.113 0.004 DBMET00933	DBMET00933
	0.105	0.068	0.105	5 Hydroxytryptamine 2 antagonist	0.093 0.078 DBMET00933
	0.11	0.074	0.164	Anesthetic local	0.164 0.043 DBMET00882	DBMET00882
	0.089	0.054	0.089	5 Hydroxytryptamine 2A antagonist	0.078 0.06 DBMET00933
	0.13	0.099	0.163	Pregnane X receptor agonist	0.163 0.033 DBMET00933	DBMET00933
	0.109	0.085	0.171	MAP kinase 12 inhibitor	0.171 0.032 DBMET00933	DBMET00933
	0.046	0.024	0.145	GABA B receptor antagonist	0.145 0.004 DBMET00933	DBMET00933
	0.061	0.039	0.061	Potassium channel (Ca-activated) blocker	0.056 0.05 DBMET00933
	0.145	0.126	0.158	P-glycoprotein inhibitor	0.158 0.104 DBMET00882	DBMET00882
	0.052	0.033	0.052	Sigma receptor antagonist
	0.08	0.063	0.099	Transforming growth factor beta 3 antagonist	0.099 0.024 DBMET00933	DBMET00933
	0.142	0.125	0.217	Death-associated protein kinase 2 inhibitor	0.217 0.024 DBMET00933	DBMET00933
	0.068	0.055	0.068	Calcium channel L-type blocker	0.064 0.061 DBMET00882
	0.032	0.02	0.032	Cholecystokinin B antagonist	0.028 0.024 DBMET00933
	0.061	0.048	0.061	Cannabinoid receptor agonist	0.057 0.051 DBMET00882
	0.153	0.143	0.153	Antiamyloidogenic
	0.073	0.065	0.073	Histamine H1 receptor antagonist
	0.046	0.042	0.083	5 Hydroxytryptamine 2 agonist	0.083 0.014 DBMET00933	DBMET00933
	0.084	0.08	0.138	MAP kinase kinase 1 inhibitor	0.115 0.039 DBMET00882 0.138 0.021 DBMET00933	DBMET00933
	0.042	0.039	0.257	Purinergic P2X4 antagonist	0.257 0.003 DBMET00933	DBMET00933
	0.072	0.07	0.124	Glycine receptor antagonist	0.124 0.016 DBMET00933	DBMET00933
	0.1	0.098	0.101	Aldehyde dehydrogenase inhibitor	0.101 0.097 DBMET00882	DBMET00882
	0.093	0.092	0.106	5 Hydroxytryptamine 2B antagonist	0.106 0.077 DBMET00933	DBMET00933
	0.134	0.132	0.185	Ca2+/calmodulin-dependent protein kinase inhibitor	0.185 0.085 DBMET00933	DBMET00933
	0.06	0.058	0.101	Nav1.7 sodium channel blocker	0.101 0.023 DBMET00933	DBMET00933
	0.09	0.089	0.228	5 Hydroxytryptamine 3A agonist	0.228 0.009 DBMET00933	DBMET00933
	0.046	0.046	0.054	Sodium/calcium exchanger inhibitor	0.046 0.044 DBMET00882 0.054 0.027 DBMET00933	DBMET00933
	0.032	0.033	0.06	Kinesin antagonist	0.06 0.014 DBMET00933	DBMET00933
	0.032	0.033	0.06	Kinesin-like protein 1 inhibitor	0.06 0.014 DBMET00933	DBMET00933
	0.031	0.041	0.044	Secretase gamma inhibitor	0.044 0.029 DBMET00933	DBMET00933
	0.124	0.135	0.164	MAP kinase kinase 4 inhibitor	0.164 0.04 DBMET00933	DBMET00933
	0.04	0.052	0.072	Benzodiazepine inverse agonist	0.072 0.009 DBMET00933	DBMET00933
	0.058	0.071	0.08	Transforming growth factor antagonist	0.08 0.035 DBMET00933	DBMET00933
	0.045	0.059	0.062	Cannabinoid CB1 receptor agonist	0.062 0.041 DBMET00882	DBMET00882
	0.053	0.067	0.083	Corticotropin releasing factor 2 receptor antagonist	0.083 0.015 DBMET00933	DBMET00933
	0.113	0.129	0.157	NOS3 expression enhancer	0.157 0.066 DBMET00933	DBMET00933
	0.048	0.065	0.076	Cannabinoid CB1 receptor antagonist	0.076 0.03 DBMET00933	DBMET00933
	0.027	0.045	0.039	p53 inhibitor	0.039 0.021 DBMET00933	DBMET00933
	0.047	0.065	0.063	5 Hydroxytryptamine 7 agonist	0.063 0.027 DBMET00933	DBMET00933
	0.034	0.057	0.059	Purinergic P2X antagonist	0.059 0.024 DBMET00933	DBMET00933
	0.076	0.1	0.117	Lanosterol 14 alpha demethylase inhibitor	0.117 0.034 DBMET00933	DBMET00933
	0.053	0.079	0.099	Potassium channel large-conductance Ca-activated activator	0.099 0.024 DBMET00933	DBMET00933
	0.071	0.099	0.134	Pim-3 kinase inhibitor	0.134 0.024 DBMET00933	DBMET00933
	0.131	0.159	0.147	Catenin beta inhibitor	0.147 0.114 DBMET00882	DBMET00882
	0.065	0.095	0.21	Potassium channel (Ca-activated) activator	0.21 0.013 DBMET00933	DBMET00933
	0.072	0.104	0.143	DNA directed RNA polymerase inhibitor	0.143 0.026 DBMET00933	DBMET00933
	0.071	0.105	0.156	Bromodomain-containing protein 2 inhibitor	0.156 0.007 DBMET00933	DBMET00933
	0.033	0.069	0.053	Transforming growth factor beta 1 antagonist	0.053 0.031 DBMET00933	DBMET00933
	0.039	0.075	0.054	Antiviral (Hepatitis D)	0.054 0.029 DBMET00933	DBMET00933
	0.031	0.069	0.06	Bromodomain-containing protein 3 inhibitor	0.06 0.02 DBMET00933	DBMET00933
	0.039	0.08	0.088	5 Hydroxytryptamine 2A agonist	0.088 0.021 DBMET00933	DBMET00933
	0.028	0.07	0.064	5 Hydroxytryptamine 2B agonist	0.064 0.007 DBMET00933	DBMET00933
	0.037	0.079	0.107	Pim-2 kinase inhibitor	0.107 0.013 DBMET00933	DBMET00933
	0.038	0.081	0.071	p38 MAP kinase inhibitor	0.071 0.044 DBMET00933	DBMET00933
	0.101	0.145	0.138	Mannose-6-phosphate isomerase inhibitor	0.138 0.077 DBMET00933	DBMET00933
	0.107	0.151	0.122	Thiol protease inhibitor	0.122 0.113 DBMET00933	DBMET00933
	0.064	0.109	0.151	Pim-1 kinase inhibitor	0.151 0.027 DBMET00933	DBMET00933
	0.045	0.091	0.065	Pregnane X receptor antagonist	0.065 0.021 DBMET00933	DBMET00933
	0.073	0.12	0.104	Glutamate release inhibitor	0.104 0.037 DBMET00933	DBMET00933
	0.032	0.083	0.046	Alpha 1L adrenoreceptor agonist	0.046 0.023 DBMET00933	DBMET00933
	0.045	0.1	0.055	Gonadotropin-releasing hormone receptor agonist	0.055 0.053 DBMET00882	DBMET00882
	0.102	0.159	0.188	TRKC antagonist	0.188 0.074 DBMET00933	DBMET00933
	0.141	0.198	0.281	5 Hydroxytryptamine release stimulant	0.281 0.076 DBMET00933	DBMET00933
	0.024	0.082	0.047	AMPA receptor antagonist	0.047 0.034 DBMET00933	DBMET00933
	0.075	0.134	0.189	MAP kinase kinase inhibitor	0.12 0.074 DBMET00882 0.189 0.032 DBMET00933	DBMET00933
	0.09	0.15	0.11	Interleukin 1 antagonist	0.11 0.104 DBMET00933	DBMET00933
	0.035	0.097	0.063	Purinergic P2 antagonist	0.063 0.045 DBMET00933	DBMET00933
	0.157	0.222	0.237	Ca2+/calmodulin-dependent kinase II alpha inhibitor	0.237 0.119 DBMET00933	DBMET00933
	0.223	0.288	0.286	Caspase 9 stimulant	0.286 0.209 DBMET00882	DBMET00882
	0.033	0.099	0.071	Phosphodiesterase VII inhibitor	0.071 0.034 DBMET00933	DBMET00933
	0.034	0.1	0.06	TRPA1 antagonist	0.06 0.044 DBMET00933	DBMET00933
	0.036	0.107	0.109	MAP kinase 11 inhibitor	0.109 0.03 DBMET00933	DBMET00933
	0.026	0.102	0.05	Adenylate cyclase 1 inhibitor	0.05 0.026 DBMET00933	DBMET00933
	0.023	0.102	0.057	Acid-sensing ion channel blocker	0.057 0.011 DBMET00933	DBMET00933
	0.175	0.256	0.288	Calcium channel activator	0.288 0.104 DBMET00933	DBMET00933
	0.037	0.126	0.063	Protein kinase C beta inhibitor	0.063 0.062 DBMET00933	DBMET00933
	0.084	0.178	0.105	Sphingosine 1-phosphate receptor 2 agonist	0.105 0.087 DBMET00882	DBMET00882
	0.164	0.263	0.201	Interleukin 2 agonist	0.201 0.188 DBMET00882	DBMET00882
	0.03	0.131	0.064	Cyclin D1 inhibitor	0.064 0.037 DBMET00933	DBMET00933
	0.032	0.133	0.071	MAP kinase 14 inhibitor	0.071 0.054 DBMET00933	DBMET00933
	0.042	0.149	0.125	NMDA receptor antagonist	0.125 0.033 DBMET00933	DBMET00933
	0.018	0.126	0.061	Factor XIa inhibitor	0.061 0.012 DBMET00933	DBMET00933
	0.067	0.182	0.111	Alkaline phosphatase inhibitor	0.111 0.098 DBMET00933	DBMET00933
	0.087	0.202	0.203	LIM domain kinase 1 inhibitor	0.203 0.061 DBMET00933	DBMET00933
	0.015	0.141	0.055	Adenosine A2b receptor antagonist	0.055 0.028 DBMET00933	DBMET00933
	0.067	0.195	0.113	NADPH oxidase inhibitor	0.113 0.092 DBMET00933	DBMET00933
	0.083	0.212	0.17	Cyclin-dependent kinase 8 inhibitor	0.17 0.061 DBMET00933	DBMET00933
	0.054	0.183	0.129	Proto-oncogene tyrosine-protein kinase Yes inhibitor	0.129 0.075 DBMET00933	DBMET00933
	0.082	0.211	0.136	Aurora-C kinase inhibitor	0.136 0.072 DBMET00933	DBMET00933
	0.009	0.139	0.032	Kainate receptor 2 antagonist	0.032 0.028 DBMET00933	DBMET00933
	0.066	0.197	0.14	Ca2+/calmodulin-dependent kinase II gamma inhibitor	0.14 0.096 DBMET00933	DBMET00933
	0.01	0.141	0.032	Potassium channel small-conductance Ca-activated activator	0.032 0.021 DBMET00933	DBMET00933
	0.053	0.191	0.084	Potassium channel (Voltage-sensitive) activator	0.084 0.079 DBMET00933	DBMET00933
	0.127	0.266	0.217	RNA-directed DNA polymerase inhibitor	0.217 0.077 DBMET00933	DBMET00933
	0.006	0.147	0.038	Progesterone antagonist	0.038 0.023 DBMET00933	DBMET00933
	0.034	0.176	0.057	Phosphodiesterase 1A inhibitor	0.057 0.048 DBMET00933	DBMET00933
	0.044	0.193	0.083	Creatine kinase inhibitor	0.083 0.082 DBMET00882	DBMET00882
	0.047	0.196	0.112	Ferrochelatase inhibitor	0.112 0.06 DBMET00933	DBMET00933
	0.137	0.29	0.178	5 Hydroxytryptamine 3E antagonist	0.178 0.111 DBMET00933	DBMET00933
	0.091	0.245	0.135	MAP kinase 3 inhibitor	0.135 0.095 DBMET00933	DBMET00933
	0.015	0.17	0.088	Glutamate (mGluR1) antagonist	0.088 0.02 DBMET00933	DBMET00933
	0.051	0.206	0.097	Protein kinase C zeta inhibitor	0.097 0.054 DBMET00933	DBMET00933
	0.009	0.169	0.04	Factor XI inhibitor	0.04 0.016 DBMET00933	DBMET00933
	0.066	0.226	0.118	Protein kinase (CK1) gamma 1 inhibitor	0.118 0.1 DBMET00933	DBMET00933
	0.016	0.179	0.048	NMDA receptor subunit 3B antagonist	0.048 0.027 DBMET00933	DBMET00933
	0.071	0.238	0.102	Transcription factor STAT6 inhibitor	0.102 0.1 DBMET00933	DBMET00933
	0.108	0.286	0.166	MAP-kinase-activated kinase 5 inhibitor	0.166 0.156 DBMET00933	DBMET00933
	0.043	0.22	0.126	EphA2 antagonist	0.126 0.049 DBMET00933	DBMET00933
	0.023	0.203	0.054	Potassium channel (ATP-sensitive) activator	0.054 0.024 DBMET00933	DBMET00933
	0.121	0.303	0.195	Vasodilator, coronary	0.195 0.187 DBMET00882	DBMET00882
	0.024	0.207	0.056	Potassium channel (Inward rectifier) activator	0.056 0.025 DBMET00933	DBMET00933
	0.067	0.253	0.142	Protein kinase (CK1) gamma 3 inhibitor	0.142 0.099 DBMET00933	DBMET00933
	0.049	0.235	0.119	Tyrosine-protein kinase receptor antagonist	0.119 0.088 DBMET00933	DBMET00933
	0.016	0.206	0.056	Dihydroorotase inhibitor	0.056 0.019 DBMET00933	DBMET00933
	0.085	0.281	0.154	Vasodilator	0.154 0.151 DBMET00882	DBMET00882
	0.083	0.281	0.151	Ca2+/calmodulin-dependent kinase I alpha inhibitor	0.151 0.144 DBMET00933	DBMET00933
	0.017	0.216	0.116	Prostaglandin-E synthase inhibitor	0.116 0.021 DBMET00933	DBMET00933
	0.043	0.242	0.116	TRKA antagonist	0.116 0.07 DBMET00933	DBMET00933
	0.004	0.205	0.036	NMDA receptor glycine site antagonist	0.036 0.009 DBMET00933	DBMET00933
	0.121	0.327	0.25	Nitric-oxide synthase stimulant	0.25 0.032 DBMET00933	DBMET00933
	0.046	0.253	0.111	Phosphodiesterase inhibitor	0.111 0.092 DBMET00933	DBMET00933
	0.043	0.252	0.107	Beta glucuronidase inhibitor	0.107 0.06 DBMET00933	DBMET00933
	0.024	0.234	0.104	Cyclin B3 inhibitor	0.104 0.027 DBMET00933	DBMET00933
	0.029	0.24	0.106	Phosphodiesterase 3A inhibitor	0.106 0.028 DBMET00933	DBMET00933
	0.028	0.243	0.075	Aryl hydrocarbon receptor antagonist	0.075 0.032 DBMET00933	DBMET00933
	0.07	0.288	0.151	Polo-like kinase-3 inhibitor	0.151 0.083 DBMET00933	DBMET00933
	0.16	0.385	0.283	5 Hydroxytryptamine release inhibitor	0.283 0.186 DBMET00933	DBMET00933
	0.014	0.241	0.078	NMDA receptor glycine site agonist	0.078 0.03 DBMET00933	DBMET00933
	0.041	0.278	0.108	Protein kinase (CK1) gamma inhibitor	0.108 0.105 DBMET00933	DBMET00933
	0.032	0.274	0.227	Glycogen synthase kinase-3 alpha inhibitor	0.227 0.034 DBMET00933	DBMET00933
	0.023	0.277	0.074	MAP-kinase-activated kinase 2 inhibitor	0.074 0.052 DBMET00933	DBMET00933
	0.042	0.307	0.104	Nav1.4 sodium channel blocker	0.104 0.07 DBMET00933	DBMET00933
	0.028	0.294	0.173	Polo-like kinase-4 inhibitor	0.173 0.024 DBMET00933	DBMET00933
	0.041	0.314	0.299	Aryl hydrocarbon receptor agonist	0.299 0.061 DBMET00933	DBMET00933
	0.092	0.365	0.159	Cyclin-dependent kinase 3 inhibitor	0.159 0.078 DBMET00933	DBMET00933
	0.027	0.302	0.081	MAP-kinase-activated kinase inhibitor	0.081 0.061 DBMET00933	DBMET00933
	0.035	0.315	0.079	GABA B receptor agonist	0.079 0.043 DBMET00933	DBMET00933
	0.039	0.32	0.143	Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor	0.143 0.126 DBMET00933	DBMET00933
	0.016	0.298	0.091	Phosphodiesterase III inhibitor	0.091 0.027 DBMET00933	DBMET00933
	0.043	0.337	0.116	Cytokine production inhibitor	0.116 0.094 DBMET00933	DBMET00933
	0.041	0.339	0.112	Nav1.5 sodium channel blocker	0.112 0.065 DBMET00933	DBMET00933
	0.007	0.318	0.104	Phosphodiesterase 3B inhibitor	0.104 0.01 DBMET00933	DBMET00933
	0.044	0.379	0.142	Death-associated protein kinase 3 inhibitor	0.142 0.136 DBMET00933	DBMET00933
	0.02	0.482	0.092	AMP-activated protein kinase stimulant	0.092 0.081 DBMET00933	DBMET00933
	0.057	0.583	0.124	Death-associated protein kinase 1 inhibitor	0.124 0.099 DBMET00933	DBMET00933
	0.072	0.797	0.335	Calcium channel L-type activator	0.335 0.129 DBMET00933	DBMET00933
Ext	Pa	Pi	Pmax	Activity	Other Results	ID Pa_max